These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6278626)

  • 21. [Recent problems on lupus systemic erythematosus].
    Honma M
    Nihon Naika Gakkai Zasshi; 1990 Oct; 79(10):1341-2. PubMed ID: 2269805
    [No Abstract]   [Full Text] [Related]  

  • 22. Perspectives in pediatric systemic lupus erythematosus.
    Ansell BM
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():177-9. PubMed ID: 3612646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and pathogenic significance of renal autoantibodies in patients with systemic lupus erythematosus].
    Mitu S; Purice S; Cernescu C; Matei I; Guran M; Vintilă M; Suţă G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(4):365-70. PubMed ID: 6140736
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pattern of antibodies against deoxyribonucleic acid in systemic lupus erythematosus (author's transl)].
    Cebecauer L; Zitnan D; Rovenský J; Lukác J
    Bratisl Lek Listy; 1981 May; 75(5):589-94. PubMed ID: 7237187
    [No Abstract]   [Full Text] [Related]  

  • 27. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus.
    Burlingame RW
    Clin Lab Med; 1997 Sep; 17(3):367-78. PubMed ID: 9316764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.
    Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD;
    Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
    Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
    Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of immune complexes in renal diseases (author's transl)].
    Smolen JS; Wolf A; Scherak O; Syre G; Pinggera W; Stummvoll HK; Leithner C; Menzel EJ
    Acta Med Austriaca; 1981; 8(2):37-41. PubMed ID: 6456639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutics for systemic lupus erythematosus.
    Wiesendanger M; Stanevsky A; Kovsky S; Diamond B
    Curr Opin Rheumatol; 2006 May; 18(3):227-35. PubMed ID: 16582684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relation of antibodies specific for asialo-T cells to renal disease activity in patients with systemic lupus erythematosus].
    Nishikawa M; Sugino N; Sakane T
    Arerugi; 1982 Nov; 31(11):1139-45. PubMed ID: 6985022
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recent considerations on systemic lupus erythematosus (author's transl)].
    Niaudet P
    Ann Pediatr (Paris); 1981 Oct; 28(8):537-43. PubMed ID: 7305231
    [No Abstract]   [Full Text] [Related]  

  • 37. B cell loss leading to remission in severe systemic lupus erythematosus.
    Tarrant TK; Frazer DH; Aya-Ay JP; Patel DD
    J Rheumatol; 2003 Feb; 30(2):412-4. PubMed ID: 12563705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lymphoreceptopathy in the patients with systemic lupus erythematosus (author's transl)].
    Arimori S
    Nihon Naika Gakkai Zasshi; 1980 Dec; 69(12):1584-9. PubMed ID: 7229477
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in rheumatology: biological agents for the treatment of rheumatoid arthritis, the progression of psoriatic arthritis, autoantibodies in systemic lupus erythematosus.
    Finucane KA; Archer CB
    Clin Exp Dermatol; 2005 Mar; 30(2):201-4. PubMed ID: 15725261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.